About Admak Pharmaceuticals Private Limited
Data last updated:
Admak Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 15 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2015PTC266651. Its GSTIN is 27AANCA6805F1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Ady Solutions Private Limited. It is led by directors including Amit Devraj Yadav and Sunita Amit Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/53 Dreamland Chs Plot No 157 – 5 Imp Power Road Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.98 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net loss of ₹2.56 Lakh (net margin -51.4%) and EBITDA of -₹2.56 Lakh (EBITDA margin -51.3%). Revenue has declined at a compounded annual rate (CAGR) of 116% over three years and 26% over five years.
Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website seraphlife.com.
Company details
CIN history
Admak Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900MH2015PTC266651. The current CIN is U24100MH2015PTC266651, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2015PTC266651 | Current |
| U74900MH2015PTC266651 | Previous |
Contact details
Admak Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is seraphlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA/53 Dreamland Chs Plot No 157 – 5 Imp Power Road Kandivali West, Mumbai, Maharashtra, India – 400067
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Admak Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Admak Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Admak Pharmaceuticals Private Limited, buy the company report.
Financials of Admak Pharmaceuticals Private Limited
FY 2025 filings availableAdmak Pharmaceuticals Private Limited reported revenue of ₹4.98 Lakh (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 35% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 26%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -51.3% | ||||
| Net Profit Margin | -51.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Admak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Admak Pharmaceuticals Private Limited
Admak Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Devraj Yadav | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Sunita Amit Yadav | Director | 11 Mar 2021 | 5 Years 7 Months | Current |
| Anil Devraj Yadav | Director | 01 Apr 2017 | 9 Years 6 Months | Current |
Auditor
Admak Pharmaceuticals Private Limited is audited by K S P M & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S P M & ASSOCIATES | FY 2021 | 104723W |
Shareholding
The shareholding of Admak Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Admak Pharmaceuticals Private Limited, buy the company report.
Legal cases
Admak Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
| High Court | Court case (COMIP) | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
To see the full case history of Admak Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Admak Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCA6805F1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Admak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Admak Pharmaceuticals Private Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Sunita Amit Yadav was appointed as Director on 11 Mar 2021.
Frequently asked questions
Admak Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 15 July 2015 (11+ years old) and is registered under CIN U24100MH2015PTC266651.
Admak Pharmaceuticals has 3 current directors:
- Amit Devraj Yadav - Director
- Sunita Amit Yadav - Director
- Anil Devraj Yadav - Director
The latest financial statements of Admak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Admak Pharmaceuticals is 27AANCA6805F1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Admak Pharmaceuticals is U24100MH2015PTC266651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admak Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Admak Pharmaceuticals was incorporated on 15 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Sunita Amit Yadav was appointed as Director on 11 Mar 2021. Kalpesh Thakorbhai Mistry ceased to be Director on 10 Mar 2021. Anil Devraj Yadav ceased to be Additional Director on 29 Sep 2018. Admak Pharmaceuticals has 8 board changes on record in total.
Admak Pharmaceuticals can be reached through the website seraphlife.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Admak Pharmaceuticals is at A53 Dreamland Chs Plot No 157 – 5 Imp Power Road Kandivali West, Mumbai, Maharashtra, India – 400067.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
